Patent 9078854 was granted and assigned to Allergan, Inc. on July, 2015 by the United States Patent and Trademark Office.
The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intra-ocular pressure and treatment of glaucoma.